Advances in Transdermal Nanoformulations: Smart Carriers for Enhanced Drug Permeation

Abstract:

Transdermal drug delivery has advanced substantially with the integration of nanoscale carriers. The combination of lipid- and polymer-based nanoparticles, nanoemulsions, and other colloidal systems with patch and microneedle platforms enables improved permeation and controlled release across the stratum corneum. Microneedle arrays fabricated from biodegradable polymers or silicon create transient microchannels in the skin, facilitating the efficient transport of both small molecules and large biotherapeutics, including peptides, proteins, and vaccines, which typically cannot penetrate intact skin. Deformable lipid vesicles, such as liposomes, ethosomes, and transfersomes, possess hydrophilic cores and lipophilic bilayers that fuse with skin lipids, thereby enhancing solubility, promoting skin deposition, and reducing systemic toxicity. Polymeric nanoparticles and nanoemulsions protect drugs against degradation and ensure sustained release. Smart, stimuli-responsive platforms have been developed to release therapeutic payloads in response to local conditions such as pH, temperature, light, or ultrasound. For instance, thermosensitive hydrogel matrices and pH-cleavable nanoparticle coatings are engineered to release cargo in the acidic microenvironments of inflamed or cancerous tissues. Targeted delivery is achieved through surface functionalization with ligands such as antibodies, peptides, or folate, which direct carriers to specific cells or diseased tissues. Further precision is obtained through microneedle designs that deposit nanoparticles at defined depths within the skin. Collectively, these nanoformulation strategies facilitate noninvasive transdermal administration of a wide spectrum of therapeutics, including agents for chronic pain, dermatological disorders, and cancer, while enhancing bioavailability and improving patient compliance.